• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOCONCEPTS DR SCHOLLS FREEZE AWAY SKIN TAG REMOVER; CRYOGENIC SKIN REMOVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOCONCEPTS DR SCHOLLS FREEZE AWAY SKIN TAG REMOVER; CRYOGENIC SKIN REMOVER Back to Search Results
Medical Device Problem Code Insufficient Information (3190)
Health Effect - Clinical Codes Erythema (1840); Pain (1994); Fluid Discharge (2686); Cancer (3262)
Date of Event 09/01/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report and the information submitted under this report do not constitute an admission that the device or scholl's wellness or any of its employees caused or contributed to the event described within this report.
 
Event or Problem Description
On 18-jan-2024, a spontaneous report from the united states was received via email regarding a 63-year-old male who used a dr.Scholls freeze away skin tag remover.On an unspecified date in (b)(6) 2023, reported as 6 months ago (relative to (b)(6) 2024), the consumer's wife topically applied the dr.Scholls freeze away skin tag remover to his lower back skin tag as he could not see the area properly.The skin tag did not freeze or fall off after application of the product.The day after application he could see a little bump in the mirror at the application site and it was sore to the touch.After a couple of days, the bump raised more.It was red and it protruded from the skin more than before.After 1 to 2 weeks the area started oozing and he believed it was infected, but he did not show it to his doctor.After a month, it was noted to be bigger and a size of a marble.It kept growing.Approximately 4 months after application, the consumer visited his doctor.The consumer thought it seemed like there was fluid under the bump.He received a referral to an oncologist surgeon.On (b)(6) 2023, the consumer had the growth removed from his back and a biopsy was taken.The size of the growth was noted to have been 5.3 cm x 2.6 cm x 1.5 cm.The biopsy revealed a well differentiated squamous cell carcinoma a keratocanthomatous type.From the surgery he had an incision with 4 by 4 scar with stitches that were painful.The area was healing well.It was anticipated that on (b)(6) 2024 he would have an appointment with a dermatologist and on 24-jan-2024, he would have an appointment with his oncologist.He thought he would have imaging done to see if the cancer had spread.On an unspecified date, the consumer asked the doctor and the surgeon if they thought it was related to use of the product, but they did not comment.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DR SCHOLLS FREEZE AWAY SKIN TAG REMOVER
Common Device Name
CRYOGENIC SKIN REMOVER
Manufacturer (Section D)
CRYOCONCEPTS
1100 convoy place
easton PA 18040
Manufacturer (Section G)
SCHOLL'S WELLNESS COMPANY
1100 convoy place
easton NJ 18040
Manufacturer Contact
alex terranova
1100 convoy place
easton, NJ 18040
8553552796
MDR Report Key18704361
Report Number3008812068-2024-00001
Device Sequence Number7676786
Product Code GEH
UDI-Device Identifier00888853003467
UDI-Public0100888853003467
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
D478237
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 02/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/18/2024
Initial Report FDA Received Date02/14/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CEPHALEXIN; LISINOPRIL
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient SexMale
Patient Weight125 KG
-
-